Bruno David
Lourenço Paiva
Forscher in der Zeit 2011-2015
![Foto de Bruno David](/img/nophoto.png)
![Foto de University of Texas MD Anderson Cancer Center](/img/noimage_org.png)
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von University of Texas MD Anderson Cancer Center (6)
2022
-
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 28, Núm. 21, pp. 4771-4781
2018
-
Richter transformation driven by Epstein–Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia
Journal of Pathology, Vol. 245, Núm. 1, pp. 61-73
2016
-
Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition
Cytometry Part B - Clinical Cytometry, Vol. 90, Núm. 1, pp. 26-30
-
Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting
Cytometry Part B - Clinical Cytometry, Vol. 90, Núm. 1, pp. 31-39
-
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557
-
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
The Lancet Oncology, Vol. 17, Núm. 8, pp. e328-e346